← Back to Patent Explorer
EP0716836A1 Expired / Lapsed EP ⏱️ 0.0 years remaining

Polymer film for wrapping a stent structure

Assignee: Abbott Cardiovascular Systems Inc
•
Filing: 1995-12-11
•
Granted: —
•
Expires: 2015-12-11
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The drug-loaded stent (20) includes an expandable stent structural member (22), and a planar sheet (24) of polymeric material attached (26) to the outside of the expandable stent structural member (22). The polymeric material (24) preferably is bioabsorbable, and loaded or coated with a therapeutic agent or drug to reduce or to prevent restenosis in the vessel being treated. The polymer material (24) can be attached to the metal stent at one or more points (26), and wrapped in a coil around the stent in an unexpanded state, to uncoil and expand in diameter to substantially match the expanded diameter of the metal stent; or can be wrapped tightly around the stent structural member (22) and attached to itself, to stretch radially when the stent structural member is expanded. In another currently preferred embodiment, a combination of a stent structural member and a polymeric film wrapping can be provided with a coating of lubricious material. The lubricious material can be polyethylene oxide, polyethylene glycol, polyethylene acetate, polyvinyl pyrrolidone, polyvinyl alcohol, polyacrylamide, hydrophilic soft segment urethanes, some natural gums, polyanhydrides or other similar hydrophilic polymers, and combinations thereof. The layer of lubricious material (120) protects the stent from the guide or the body lumen in which the stent is inserted by providing a low friction surface over the stent.

Inventors

  • 👤 Joseph M Tartaglia
  • 👤 Joseph P. Loeffler
  • 👤 Todd H Turnlund

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-10-23 09:54
CPC Classifications
A; A61; A61F; A61F2/00; A61F2/82; A61F2/02; A61F2/04; A61F2/06; A61F2/07; A61F2/92; A61F2/86; A61F2/90; A61F2/91; A61F2/915; A61F2002/075; A61F2220/00; A61F2220/0025; A61F2220/005; A61F2250/00; A61F2250/0058; A61F2250/0067

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 31 words
A drug-loaded stent, comprising: an expandable stent structural member; and a planar sheet of polymeric material disposed on the stent structural member, said polymeric material being loaded with a therapeutic agent.
Claim 2
Dependent Claim 23 words
The drug-loaded stent of Claim 1, wherein said planar sheet of polymeric material is wrapped in a coil around the stent structural member.
Claim 3
Dependent Claim 36 words
The drug-loaded stent of Claim 1, wherein said planar sheet of polymeric material is wrapped circumferentially around the stent structural member at least one time, and said planar sheet of polymeric material is attached to itself.
Claim 4
Dependent Claim 42 words
The drug-loaded stent of Claim 1, wherein said planar sheet of polymeric material is wrapped circumferentially around the stent structural member at least one time, and said planar sheet of polymeric material is attached to the stent structural member by interference fit.
Claim 5
Dependent Claim 41 words
The drug-loaded stent of Claim 1, wherein said planar sheet of polymeric material is wrapped circumferentially around the stent structural member at least one time, and said planar sheet of polymeric material is attached to the stent structural member by adhesive.
Claim 6
Dependent Claim 121 words
The drug-loaded stent of Claim 1, wherein said stent structural member has a surface defining a plurality of slotted openings therethrough and a plurality of structural ribs, said planar sheet of polymeric material has at least one attachment tab having an aperture therethrough and a slit extending from said aperture to an outside edge of said attachment tab, said planar sheet of polymeric material being attached to the stent structural member by inserting said attachment tab into one said stent stent slotted opening and hooking said slit and said aperture of said attacment tab to a structural rib of said stent structural member, and said sheet of polymeric material is wrapped circumferentially around the stent structural member at least one time.
Claim 7
Dependent Claim 38 words
The drug-loaded stent of Claim 3, wherein said planar sheet of polymeric material is selected from the group of polymers consisting of thermoplastic and elastomeric polymers, whereby said film stretches radially when said stent structural member is expanded.
Claim 8
Dependent Claim 29 words
The drug-loaded stent of Claim 2, wherein said planar sheet of polymeric material is adapted to uncoil and expand to substantially match the expansion of said stent structural member.
Claim 9
Dependent Claim 45 words
The drug-loaded stent of Claim 2, wherein said stent structural member has a longitudinal axis, and said planar sheet of polymeric material has at least one slit transverse to the axis of said stent structural member to accommodate uneven expansion of the stent structural member.
Claim 10
Dependent Claim 27 words
The drug-loaded stent of Claim 1, wherein said therapeutic agent is selected from the group consisting of therapeutic agents consisting of antiplatelets, antithrombins, cytostatic and antiproliferative agents.
Claim 11
Dependent Claim 94 words
The drug-loaded stent of Claim 1, wherein said therapeutic agent is selected from the group of therapeutic agents consisting of sodium heparin, low molecular weight heparin, hirudin, argatroban, forskolin, vapiprost, prostacyclin and prostacyclin analogues, dextran, D-phe-pro-arg-chloromethylketone, dipyridamole, glycoprotein IIb/IIIa platelet membrane receptor antibody, recombinant hirudin, thrombin inhibitor, angiopeptin, angiotensin converting enzyme inhibitors, calcium channel blockers, colchicine, fibroblast growth factor antagonists, fish oil, omega 3-fatty acid, histamine antagonists, HMG-CoA reductase inhibitor, methotrexate, monoclonal antibodies, nitroprusside, phosphodiesterase inhibitors, prostaglandin inhibitor, serotonin blockers, steroids, thioprotease inhibitors, triazolopyrimidine, PDGF antagonists, alpha-interferon, genetically engineered epithelial cells, and combinations thereof.
Claim 12
Dependent Claim 36 words
The drug-loaded stent of Claim 1, wherein said stent structural member is formed from a metal selected from the group of metals consisting of stainless steel, tantalum, nickel-titanium alloy, platinum-iridium alloy, gold, magnesium, MP35N, and MP20N.
Claim 13
Dependent Claim 25 words
The drug-loaded stent of Claim 1, wherein said planar sheet of polymeric material has a surface defining a plurality of openings to promote rapid endothelialization.
Claim 14
Dependent Claim 23 words
The drug-loaded stent of Claim 1, wherein said planar sheet of polymeric material is coated with a layer of hydrophilic lubricious polymeric material.
Claim 15
Dependent Claim 39 words
The drug-loaded stent of Claim 14, wherein said lubricious material is selected from the group consisting of polyethylene oxide, polyethylene glycol, polyethylene acetate, polyvinyl pyrrolidone, polyvinyl alcohol, polyacrylamide, hydrophylic soft segment urethane, gum arabic, gum tragacanth, and combinations thereof.

References Cited (Backward Citations)

EP0578998A1 Cited
EP0604022A1 Cited
DE4407079A1 Cited
EP0621017A1 Cited
WO1995029647A2 Cited

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag